Prothena Corp (PRTA) Stock Price, Quote, News & History | Benzinga

Prothena Corp PLC (PRTA) Stock Price, Quote, News & History

PRTANASDAQ

Trade with Public

Trade with Public

$8.93

0.445.18%

At close: Jun 18, 5:00 PM EST

$8.93

N/A

After Hours: Jun 18, 4:36 PM EST

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$8.63

Close

$8.93

Volume / Avg.

1.39M / 507.74K

Day Range

$8.52 - $9.15

52 Wk Range

5.51 - 11.80

Market Cap

$467.51M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

17.73%

Days to Cover

13.85

Recent Prothena Corporation PLC News

Novo Nordisk's $100 Million Coramitug Shows Promise In Reducing Heart Failure Biomarker

Novo Nordisk's Coramitug cut NT-proBNP levels and was well tolerated in a Phase 2 ATTR-CM trial, paving the way for its Phase 3 CLEOPATTRA study.

Vandana Singh

FDA Tightens Safety Guidelines For Biogen Leqembi Alzheimer's Therapy

The FDA now requires earlier MRI screening for Alzheimer's drug Leqembi to detect ARIA-E, a rare but serious side effect, aiming to improve treatment safety for patients.

Vandana Singh

Roche-Prothena Partnered Mid-Stage Parkinson's Trial Misses Primary Endpoint, But Cling On Signs Of Clinical Benefits

Prothena and Roche report Phase 2b PADOVA results on prasinezumab in Parkinson's, showing promising trends and nominal significance in key analyses.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-81.34M

Investing Cash Flow (TTM)

-96.00K

Financing Cash Flow (TTM)

-7.04M

Free Cash Flow (TTM)

-81.44M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-88.47M

Analyst Trends and Forecast

0

0

0

0

Feb

0

0

0

0

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$145.71M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

7.90

PB Ratio (TTM)

1.42

Earnings Yield % (TTM)

-33.10%

Earnings Yield % (FWD)

-1.83%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$5.97

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$329.46M

Debt to Equity

0.02

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$8.63

Close

$8.93

Volume / Avg.

1.39M / 507.74K

Day Range

$8.52 - $9.15

52 Wk Range

5.51 - 11.80

Market Cap

$467.51M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

17.73%

Days to Cover

13.85

About

Sector

Health Care

Industry

Biotechnology

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amy...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Prothena Corp (PRTA) stock?

A

You can purchase shares of Prothena Corp (NASDAQ:PRTA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Prothena Corp (PRTA) competitors?

A

There are no as such competitors for Prothena Corp.

Q

What is the forecast, or price target, for Prothena Corp (PRTA) stock?

A

Prothena Corp has a consensus price target of $27.82.

Q

What is the current price for Prothena Corp (PRTA)?

A

The stock price for Prothena Corp (NASDAQ: PRTA) is $8.93 last updated June 18, 2026 at 4:36 PM EDT.

Q

Does Prothena Corp (PRTA) pay a dividend?

A

There are no upcoming dividends for Prothena Corp.

Q

When is Prothena Corp (NASDAQ:PRTA) reporting earnings?

A

Prothena Corp does not have any upcoming earnings scheduled.

Q

Is Prothena Corp (PRTA) going to split?

A

There is no upcoming split for Prothena Corp.

Q

What sector and industry does Prothena Corp (PRTA) operate in?

A

Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.